Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-021050

Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)

  • Sr VP/Chief Commercial Officer gave up 1,250 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cearnal Martin E Sr VP/Chief Commercial Officer 2019-03-22 Grant or award +5,000 $5.98 $29,900 149,667 D
Cearnal Martin E Sr VP/Chief Commercial Officer 2019-03-22 Shares withheld for taxes −1,250 $5.62 $7,025 148,417 D
Loading xslF345X03/doc4.xml…